Global Phage Therapy Market Research Report 2026(Status and Outlook)
Phages, formally known as bacteriophages, are viruses that solely kill and selectively target bacteria. They are the most common biological entities in nature, and have been shown to effectively fight and destroy multi-drug resistant bacteria. Namely, when all antibiotics fail, phages still succeed in killing the bacteria and may save a life from an infection. phage has many potential applications in human medicine as well as dentistry, veterinary science, and agriculture.The Bacteriophage market is expected to grow at a significant rate owing to rising prevalence of antibiotic resistant infection, rising research activities for and development of novel therapies, increasing adoption of growth strategies such as acquisitions, and collaborations by market players.Bacteriophage is a type of virus that attaches itself to a bacterium and infects the host cell, subsequently destroying it. These microorganisms destroy their host cells through a natural process without interacting with human or animal cells. One of the most important sectors where the use of bacteriophages has emerged as very important is the poultry and aquaculture. While the use of bacteriophages in humans is still a rarity in modern medicine, their usage in animal husbandry, rearing poultry and fish is already showing positive results.The major global companies of Bacteriophage include NPO Microgen, Qingdao Phagepharm Bio-tech, Armata Pharmaceuticals, Inc., Phaxiam Therapeutics, Eliava BioPreparations, Intralytix, MicroMir, Phagelux, and Pharmex Group, LLC, etc. In 2024, the world's top five vendors accounted for approximately 48% of the revenue.
The global Phage Therapy market size was estimated at USD 55.25 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 19.30% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Phage Therapy market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Phage Therapy market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Phage Therapy market.
Global Phage Therapy Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
NPO Microgen
Qingdao Phagepharm Bio-tech
Armata Pharmaceuticals, Inc.
Phaxiam Therapeutics
Eliava BioPreparations
Intralytix
MicroMir
Phagelux
Pharmex Group, LLC
APS Biocontrol Ltd. (APS)
ACD Pharma
Proteon Pharmaceuticals
Micreos
Locus Biosciences, Inc
NexaBiome Limited
PhagePro
BiomX
INtODEWORLD, Inc.
TechnoPhage
PhageLab
SciPhage
Kinzbio
Market Segmentation (by Type)
DsDNA Bacteriophage
SsDNA Bacteriophage
SsRNA Bacteriophage
Others
Market Segmentation (by Application)
Human Health
Animal Health
Aquaculture
Agriculture
Food Industry
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Phage Therapy Market
Overview of the regional outlook of the Phage Therapy Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Phage Therapy Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Phage Therapy, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global Phage Therapy market size was estimated at USD 55.25 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 19.30% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Phage Therapy market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Phage Therapy market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Phage Therapy market.
Global Phage Therapy Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
NPO Microgen
Qingdao Phagepharm Bio-tech
Armata Pharmaceuticals, Inc.
Phaxiam Therapeutics
Eliava BioPreparations
Intralytix
MicroMir
Phagelux
Pharmex Group, LLC
APS Biocontrol Ltd. (APS)
ACD Pharma
Proteon Pharmaceuticals
Micreos
Locus Biosciences, Inc
NexaBiome Limited
PhagePro
BiomX
INtODEWORLD, Inc.
TechnoPhage
PhageLab
SciPhage
Kinzbio
Market Segmentation (by Type)
DsDNA Bacteriophage
SsDNA Bacteriophage
SsRNA Bacteriophage
Others
Market Segmentation (by Application)
Human Health
Animal Health
Aquaculture
Agriculture
Food Industry
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Phage Therapy Market
Overview of the regional outlook of the Phage Therapy Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Phage Therapy Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Phage Therapy, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Phage Therapy
1.2 Key Market Segments
1.2.1 Phage Therapy Segment by Type
1.2.2 Phage Therapy Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 PHAGE THERAPY MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Phage Therapy Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Phage Therapy Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 PHAGE THERAPY MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Phage Therapy Product Life Cycle
3.3 Global Phage Therapy Sales by Manufacturers (2020-2025)
3.4 Global Phage Therapy Revenue Market Share by Manufacturers (2020-2025)
3.5 Phage Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Phage Therapy Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Phage Therapy Market Competitive Situation and Trends
3.8.1 Phage Therapy Market Concentration Rate
3.8.2 Global 5 and 10 Largest Phage Therapy Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 PHAGE THERAPY INDUSTRY CHAIN ANALYSIS
4.1 Phage Therapy Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF PHAGE THERAPY MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Phage Therapy Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Phage Therapy Market
5.7 ESG Ratings of Leading Companies
6 PHAGE THERAPY MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Phage Therapy Sales Market Share by Type (2020-2025)
6.3 Global Phage Therapy Market Size by Type (2020-2025)
6.4 Global Phage Therapy Price by Type (2020-2025)
7 PHAGE THERAPY MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Phage Therapy Market Sales by Application (2020-2025)
7.3 Global Phage Therapy Market Size (M USD) by Application (2020-2025)
7.4 Global Phage Therapy Sales Growth Rate by Application (2020-2025)
8 PHAGE THERAPY MARKET SALES BY REGION
8.1 Global Phage Therapy Sales by Region
8.1.1 Global Phage Therapy Sales by Region
8.1.2 Global Phage Therapy Sales Market Share by Region
8.2 Global Phage Therapy Market Size by Region
8.2.1 Global Phage Therapy Market Size by Region
8.2.2 Global Phage Therapy Market Size by Region
8.3 North America
8.3.1 North America Phage Therapy Sales by Country
8.3.2 North America Phage Therapy Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Phage Therapy Sales by Country
8.4.2 Europe Phage Therapy Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Phage Therapy Sales by Region
8.5.2 Asia Pacific Phage Therapy Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Phage Therapy Sales by Country
8.6.2 South America Phage Therapy Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Phage Therapy Sales by Region
8.7.2 Middle East and Africa Phage Therapy Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 PHAGE THERAPY MARKET PRODUCTION BY REGION
9.1 Global Production of Phage Therapy by Region(2020-2025)
9.2 Global Phage Therapy Revenue Market Share by Region (2020-2025)
9.3 Global Phage Therapy Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Phage Therapy Production
9.4.1 North America Phage Therapy Production Growth Rate (2020-2025)
9.4.2 North America Phage Therapy Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Phage Therapy Production
9.5.1 Europe Phage Therapy Production Growth Rate (2020-2025)
9.5.2 Europe Phage Therapy Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Phage Therapy Production (2020-2025)
9.6.1 Japan Phage Therapy Production Growth Rate (2020-2025)
9.6.2 Japan Phage Therapy Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Phage Therapy Production (2020-2025)
9.7.1 China Phage Therapy Production Growth Rate (2020-2025)
9.7.2 China Phage Therapy Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 NPO Microgen
10.1.1 NPO Microgen Basic Information
10.1.2 NPO Microgen Phage Therapy Product Overview
10.1.3 NPO Microgen Phage Therapy Product Market Performance
10.1.4 NPO Microgen Business Overview
10.1.5 NPO Microgen SWOT Analysis
10.1.6 NPO Microgen Recent Developments
10.2 Qingdao Phagepharm Bio-tech
10.2.1 Qingdao Phagepharm Bio-tech Basic Information
10.2.2 Qingdao Phagepharm Bio-tech Phage Therapy Product Overview
10.2.3 Qingdao Phagepharm Bio-tech Phage Therapy Product Market Performance
10.2.4 Qingdao Phagepharm Bio-tech Business Overview
10.2.5 Qingdao Phagepharm Bio-tech SWOT Analysis
10.2.6 Qingdao Phagepharm Bio-tech Recent Developments
10.3 Armata Pharmaceuticals, Inc.
10.3.1 Armata Pharmaceuticals, Inc. Basic Information
10.3.2 Armata Pharmaceuticals, Inc. Phage Therapy Product Overview
10.3.3 Armata Pharmaceuticals, Inc. Phage Therapy Product Market Performance
10.3.4 Armata Pharmaceuticals, Inc. Business Overview
10.3.5 Armata Pharmaceuticals, Inc. SWOT Analysis
10.3.6 Armata Pharmaceuticals, Inc. Recent Developments
10.4 Phaxiam Therapeutics
10.4.1 Phaxiam Therapeutics Basic Information
10.4.2 Phaxiam Therapeutics Phage Therapy Product Overview
10.4.3 Phaxiam Therapeutics Phage Therapy Product Market Performance
10.4.4 Phaxiam Therapeutics Business Overview
10.4.5 Phaxiam Therapeutics Recent Developments
10.5 Eliava BioPreparations
10.5.1 Eliava BioPreparations Basic Information
10.5.2 Eliava BioPreparations Phage Therapy Product Overview
10.5.3 Eliava BioPreparations Phage Therapy Product Market Performance
10.5.4 Eliava BioPreparations Business Overview
10.5.5 Eliava BioPreparations Recent Developments
10.6 Intralytix
10.6.1 Intralytix Basic Information
10.6.2 Intralytix Phage Therapy Product Overview
10.6.3 Intralytix Phage Therapy Product Market Performance
10.6.4 Intralytix Business Overview
10.6.5 Intralytix Recent Developments
10.7 MicroMir
10.7.1 MicroMir Basic Information
10.7.2 MicroMir Phage Therapy Product Overview
10.7.3 MicroMir Phage Therapy Product Market Performance
10.7.4 MicroMir Business Overview
10.7.5 MicroMir Recent Developments
10.8 Phagelux
10.8.1 Phagelux Basic Information
10.8.2 Phagelux Phage Therapy Product Overview
10.8.3 Phagelux Phage Therapy Product Market Performance
10.8.4 Phagelux Business Overview
10.8.5 Phagelux Recent Developments
10.9 Pharmex Group, LLC
10.9.1 Pharmex Group, LLC Basic Information
10.9.2 Pharmex Group, LLC Phage Therapy Product Overview
10.9.3 Pharmex Group, LLC Phage Therapy Product Market Performance
10.9.4 Pharmex Group, LLC Business Overview
10.9.5 Pharmex Group, LLC Recent Developments
10.10 APS Biocontrol Ltd. (APS)
10.10.1 APS Biocontrol Ltd. (APS) Basic Information
10.10.2 APS Biocontrol Ltd. (APS) Phage Therapy Product Overview
10.10.3 APS Biocontrol Ltd. (APS) Phage Therapy Product Market Performance
10.10.4 APS Biocontrol Ltd. (APS) Business Overview
10.10.5 APS Biocontrol Ltd. (APS) Recent Developments
10.11 ACD Pharma
10.11.1 ACD Pharma Basic Information
10.11.2 ACD Pharma Phage Therapy Product Overview
10.11.3 ACD Pharma Phage Therapy Product Market Performance
10.11.4 ACD Pharma Business Overview
10.11.5 ACD Pharma Recent Developments
10.12 Proteon Pharmaceuticals
10.12.1 Proteon Pharmaceuticals Basic Information
10.12.2 Proteon Pharmaceuticals Phage Therapy Product Overview
10.12.3 Proteon Pharmaceuticals Phage Therapy Product Market Performance
10.12.4 Proteon Pharmaceuticals Business Overview
10.12.5 Proteon Pharmaceuticals Recent Developments
10.13 Micreos
10.13.1 Micreos Basic Information
10.13.2 Micreos Phage Therapy Product Overview
10.13.3 Micreos Phage Therapy Product Market Performance
10.13.4 Micreos Business Overview
10.13.5 Micreos Recent Developments
10.14 Locus Biosciences, Inc
10.14.1 Locus Biosciences, Inc Basic Information
10.14.2 Locus Biosciences, Inc Phage Therapy Product Overview
10.14.3 Locus Biosciences, Inc Phage Therapy Product Market Performance
10.14.4 Locus Biosciences, Inc Business Overview
10.14.5 Locus Biosciences, Inc Recent Developments
10.15 NexaBiome Limited
10.15.1 NexaBiome Limited Basic Information
10.15.2 NexaBiome Limited Phage Therapy Product Overview
10.15.3 NexaBiome Limited Phage Therapy Product Market Performance
10.15.4 NexaBiome Limited Business Overview
10.15.5 NexaBiome Limited Recent Developments
10.16 PhagePro
10.16.1 PhagePro Basic Information
10.16.2 PhagePro Phage Therapy Product Overview
10.16.3 PhagePro Phage Therapy Product Market Performance
10.16.4 PhagePro Business Overview
10.16.5 PhagePro Recent Developments
10.17 BiomX
10.17.1 BiomX Basic Information
10.17.2 BiomX Phage Therapy Product Overview
10.17.3 BiomX Phage Therapy Product Market Performance
10.17.4 BiomX Business Overview
10.17.5 BiomX Recent Developments
10.18 INtODEWORLD, Inc.
10.18.1 INtODEWORLD, Inc. Basic Information
10.18.2 INtODEWORLD, Inc. Phage Therapy Product Overview
10.18.3 INtODEWORLD, Inc. Phage Therapy Product Market Performance
10.18.4 INtODEWORLD, Inc. Business Overview
10.18.5 INtODEWORLD, Inc. Recent Developments
10.19 TechnoPhage
10.19.1 TechnoPhage Basic Information
10.19.2 TechnoPhage Phage Therapy Product Overview
10.19.3 TechnoPhage Phage Therapy Product Market Performance
10.19.4 TechnoPhage Business Overview
10.19.5 TechnoPhage Recent Developments
10.20 PhageLab
10.20.1 PhageLab Basic Information
10.20.2 PhageLab Phage Therapy Product Overview
10.20.3 PhageLab Phage Therapy Product Market Performance
10.20.4 PhageLab Business Overview
10.20.5 PhageLab Recent Developments
10.21 SciPhage
10.21.1 SciPhage Basic Information
10.21.2 SciPhage Phage Therapy Product Overview
10.21.3 SciPhage Phage Therapy Product Market Performance
10.21.4 SciPhage Business Overview
10.21.5 SciPhage Recent Developments
10.22 Kinzbio
10.22.1 Kinzbio Basic Information
10.22.2 Kinzbio Phage Therapy Product Overview
10.22.3 Kinzbio Phage Therapy Product Market Performance
10.22.4 Kinzbio Business Overview
10.22.5 Kinzbio Recent Developments
11 PHAGE THERAPY MARKET FORECAST BY REGION
11.1 Global Phage Therapy Market Size Forecast
11.2 Global Phage Therapy Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Phage Therapy Market Size Forecast by Country
11.2.3 Asia Pacific Phage Therapy Market Size Forecast by Region
11.2.4 South America Phage Therapy Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Phage Therapy by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Phage Therapy Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Phage Therapy by Type (2026-2035)
12.1.2 Global Phage Therapy Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Phage Therapy by Type (2026-2035)
12.2 Global Phage Therapy Market Forecast by Application (2026-2035)
12.2.1 Global Phage Therapy Sales (K Units) Forecast by Application
12.2.2 Global Phage Therapy Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Phage Therapy
1.2 Key Market Segments
1.2.1 Phage Therapy Segment by Type
1.2.2 Phage Therapy Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 PHAGE THERAPY MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Phage Therapy Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Phage Therapy Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 PHAGE THERAPY MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Phage Therapy Product Life Cycle
3.3 Global Phage Therapy Sales by Manufacturers (2020-2025)
3.4 Global Phage Therapy Revenue Market Share by Manufacturers (2020-2025)
3.5 Phage Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Phage Therapy Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Phage Therapy Market Competitive Situation and Trends
3.8.1 Phage Therapy Market Concentration Rate
3.8.2 Global 5 and 10 Largest Phage Therapy Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 PHAGE THERAPY INDUSTRY CHAIN ANALYSIS
4.1 Phage Therapy Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF PHAGE THERAPY MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Phage Therapy Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Phage Therapy Market
5.7 ESG Ratings of Leading Companies
6 PHAGE THERAPY MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Phage Therapy Sales Market Share by Type (2020-2025)
6.3 Global Phage Therapy Market Size by Type (2020-2025)
6.4 Global Phage Therapy Price by Type (2020-2025)
7 PHAGE THERAPY MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Phage Therapy Market Sales by Application (2020-2025)
7.3 Global Phage Therapy Market Size (M USD) by Application (2020-2025)
7.4 Global Phage Therapy Sales Growth Rate by Application (2020-2025)
8 PHAGE THERAPY MARKET SALES BY REGION
8.1 Global Phage Therapy Sales by Region
8.1.1 Global Phage Therapy Sales by Region
8.1.2 Global Phage Therapy Sales Market Share by Region
8.2 Global Phage Therapy Market Size by Region
8.2.1 Global Phage Therapy Market Size by Region
8.2.2 Global Phage Therapy Market Size by Region
8.3 North America
8.3.1 North America Phage Therapy Sales by Country
8.3.2 North America Phage Therapy Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Phage Therapy Sales by Country
8.4.2 Europe Phage Therapy Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Phage Therapy Sales by Region
8.5.2 Asia Pacific Phage Therapy Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Phage Therapy Sales by Country
8.6.2 South America Phage Therapy Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Phage Therapy Sales by Region
8.7.2 Middle East and Africa Phage Therapy Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 PHAGE THERAPY MARKET PRODUCTION BY REGION
9.1 Global Production of Phage Therapy by Region(2020-2025)
9.2 Global Phage Therapy Revenue Market Share by Region (2020-2025)
9.3 Global Phage Therapy Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Phage Therapy Production
9.4.1 North America Phage Therapy Production Growth Rate (2020-2025)
9.4.2 North America Phage Therapy Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Phage Therapy Production
9.5.1 Europe Phage Therapy Production Growth Rate (2020-2025)
9.5.2 Europe Phage Therapy Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Phage Therapy Production (2020-2025)
9.6.1 Japan Phage Therapy Production Growth Rate (2020-2025)
9.6.2 Japan Phage Therapy Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Phage Therapy Production (2020-2025)
9.7.1 China Phage Therapy Production Growth Rate (2020-2025)
9.7.2 China Phage Therapy Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 NPO Microgen
10.1.1 NPO Microgen Basic Information
10.1.2 NPO Microgen Phage Therapy Product Overview
10.1.3 NPO Microgen Phage Therapy Product Market Performance
10.1.4 NPO Microgen Business Overview
10.1.5 NPO Microgen SWOT Analysis
10.1.6 NPO Microgen Recent Developments
10.2 Qingdao Phagepharm Bio-tech
10.2.1 Qingdao Phagepharm Bio-tech Basic Information
10.2.2 Qingdao Phagepharm Bio-tech Phage Therapy Product Overview
10.2.3 Qingdao Phagepharm Bio-tech Phage Therapy Product Market Performance
10.2.4 Qingdao Phagepharm Bio-tech Business Overview
10.2.5 Qingdao Phagepharm Bio-tech SWOT Analysis
10.2.6 Qingdao Phagepharm Bio-tech Recent Developments
10.3 Armata Pharmaceuticals, Inc.
10.3.1 Armata Pharmaceuticals, Inc. Basic Information
10.3.2 Armata Pharmaceuticals, Inc. Phage Therapy Product Overview
10.3.3 Armata Pharmaceuticals, Inc. Phage Therapy Product Market Performance
10.3.4 Armata Pharmaceuticals, Inc. Business Overview
10.3.5 Armata Pharmaceuticals, Inc. SWOT Analysis
10.3.6 Armata Pharmaceuticals, Inc. Recent Developments
10.4 Phaxiam Therapeutics
10.4.1 Phaxiam Therapeutics Basic Information
10.4.2 Phaxiam Therapeutics Phage Therapy Product Overview
10.4.3 Phaxiam Therapeutics Phage Therapy Product Market Performance
10.4.4 Phaxiam Therapeutics Business Overview
10.4.5 Phaxiam Therapeutics Recent Developments
10.5 Eliava BioPreparations
10.5.1 Eliava BioPreparations Basic Information
10.5.2 Eliava BioPreparations Phage Therapy Product Overview
10.5.3 Eliava BioPreparations Phage Therapy Product Market Performance
10.5.4 Eliava BioPreparations Business Overview
10.5.5 Eliava BioPreparations Recent Developments
10.6 Intralytix
10.6.1 Intralytix Basic Information
10.6.2 Intralytix Phage Therapy Product Overview
10.6.3 Intralytix Phage Therapy Product Market Performance
10.6.4 Intralytix Business Overview
10.6.5 Intralytix Recent Developments
10.7 MicroMir
10.7.1 MicroMir Basic Information
10.7.2 MicroMir Phage Therapy Product Overview
10.7.3 MicroMir Phage Therapy Product Market Performance
10.7.4 MicroMir Business Overview
10.7.5 MicroMir Recent Developments
10.8 Phagelux
10.8.1 Phagelux Basic Information
10.8.2 Phagelux Phage Therapy Product Overview
10.8.3 Phagelux Phage Therapy Product Market Performance
10.8.4 Phagelux Business Overview
10.8.5 Phagelux Recent Developments
10.9 Pharmex Group, LLC
10.9.1 Pharmex Group, LLC Basic Information
10.9.2 Pharmex Group, LLC Phage Therapy Product Overview
10.9.3 Pharmex Group, LLC Phage Therapy Product Market Performance
10.9.4 Pharmex Group, LLC Business Overview
10.9.5 Pharmex Group, LLC Recent Developments
10.10 APS Biocontrol Ltd. (APS)
10.10.1 APS Biocontrol Ltd. (APS) Basic Information
10.10.2 APS Biocontrol Ltd. (APS) Phage Therapy Product Overview
10.10.3 APS Biocontrol Ltd. (APS) Phage Therapy Product Market Performance
10.10.4 APS Biocontrol Ltd. (APS) Business Overview
10.10.5 APS Biocontrol Ltd. (APS) Recent Developments
10.11 ACD Pharma
10.11.1 ACD Pharma Basic Information
10.11.2 ACD Pharma Phage Therapy Product Overview
10.11.3 ACD Pharma Phage Therapy Product Market Performance
10.11.4 ACD Pharma Business Overview
10.11.5 ACD Pharma Recent Developments
10.12 Proteon Pharmaceuticals
10.12.1 Proteon Pharmaceuticals Basic Information
10.12.2 Proteon Pharmaceuticals Phage Therapy Product Overview
10.12.3 Proteon Pharmaceuticals Phage Therapy Product Market Performance
10.12.4 Proteon Pharmaceuticals Business Overview
10.12.5 Proteon Pharmaceuticals Recent Developments
10.13 Micreos
10.13.1 Micreos Basic Information
10.13.2 Micreos Phage Therapy Product Overview
10.13.3 Micreos Phage Therapy Product Market Performance
10.13.4 Micreos Business Overview
10.13.5 Micreos Recent Developments
10.14 Locus Biosciences, Inc
10.14.1 Locus Biosciences, Inc Basic Information
10.14.2 Locus Biosciences, Inc Phage Therapy Product Overview
10.14.3 Locus Biosciences, Inc Phage Therapy Product Market Performance
10.14.4 Locus Biosciences, Inc Business Overview
10.14.5 Locus Biosciences, Inc Recent Developments
10.15 NexaBiome Limited
10.15.1 NexaBiome Limited Basic Information
10.15.2 NexaBiome Limited Phage Therapy Product Overview
10.15.3 NexaBiome Limited Phage Therapy Product Market Performance
10.15.4 NexaBiome Limited Business Overview
10.15.5 NexaBiome Limited Recent Developments
10.16 PhagePro
10.16.1 PhagePro Basic Information
10.16.2 PhagePro Phage Therapy Product Overview
10.16.3 PhagePro Phage Therapy Product Market Performance
10.16.4 PhagePro Business Overview
10.16.5 PhagePro Recent Developments
10.17 BiomX
10.17.1 BiomX Basic Information
10.17.2 BiomX Phage Therapy Product Overview
10.17.3 BiomX Phage Therapy Product Market Performance
10.17.4 BiomX Business Overview
10.17.5 BiomX Recent Developments
10.18 INtODEWORLD, Inc.
10.18.1 INtODEWORLD, Inc. Basic Information
10.18.2 INtODEWORLD, Inc. Phage Therapy Product Overview
10.18.3 INtODEWORLD, Inc. Phage Therapy Product Market Performance
10.18.4 INtODEWORLD, Inc. Business Overview
10.18.5 INtODEWORLD, Inc. Recent Developments
10.19 TechnoPhage
10.19.1 TechnoPhage Basic Information
10.19.2 TechnoPhage Phage Therapy Product Overview
10.19.3 TechnoPhage Phage Therapy Product Market Performance
10.19.4 TechnoPhage Business Overview
10.19.5 TechnoPhage Recent Developments
10.20 PhageLab
10.20.1 PhageLab Basic Information
10.20.2 PhageLab Phage Therapy Product Overview
10.20.3 PhageLab Phage Therapy Product Market Performance
10.20.4 PhageLab Business Overview
10.20.5 PhageLab Recent Developments
10.21 SciPhage
10.21.1 SciPhage Basic Information
10.21.2 SciPhage Phage Therapy Product Overview
10.21.3 SciPhage Phage Therapy Product Market Performance
10.21.4 SciPhage Business Overview
10.21.5 SciPhage Recent Developments
10.22 Kinzbio
10.22.1 Kinzbio Basic Information
10.22.2 Kinzbio Phage Therapy Product Overview
10.22.3 Kinzbio Phage Therapy Product Market Performance
10.22.4 Kinzbio Business Overview
10.22.5 Kinzbio Recent Developments
11 PHAGE THERAPY MARKET FORECAST BY REGION
11.1 Global Phage Therapy Market Size Forecast
11.2 Global Phage Therapy Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Phage Therapy Market Size Forecast by Country
11.2.3 Asia Pacific Phage Therapy Market Size Forecast by Region
11.2.4 South America Phage Therapy Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Phage Therapy by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Phage Therapy Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Phage Therapy by Type (2026-2035)
12.1.2 Global Phage Therapy Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Phage Therapy by Type (2026-2035)
12.2 Global Phage Therapy Market Forecast by Application (2026-2035)
12.2.1 Global Phage Therapy Sales (K Units) Forecast by Application
12.2.2 Global Phage Therapy Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Phage Therapy Market Size by Type (M USD)
Table 4. Global Phage Therapy Market Size by Application
Table 5. Phage Therapy Market Size Comparison by Region (M USD)
Table 6. Global Phage Therapy Sales (K Units) by Manufacturers (2020-2025)
Table 7. Global Phage Therapy Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Phage Therapy Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Phage Therapy Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Phage Therapy as of 2025)
Table 11. Global Market Phage Therapy Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Phage Therapy Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Phage Therapy Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Phage Therapy Sales by Type (K Units)
Table 27. Global Phage Therapy Market Size by Type (M USD)
Table 28. Global Phage Therapy Sales (K Units) by Type (2020-2025)
Table 29. Global Phage Therapy Sales Market Share by Type (2020-2025)
Table 30. Global Phage Therapy Market Size (M USD) by Type (2020-2025)
Table 31. Global Phage Therapy Market Share by Type (2020-2025)
Table 32. Global Phage Therapy Price (USD/Unit) by Type (2020-2025)
Table 33. Global Phage Therapy Sales (K Units) by Application
Table 34. Global Phage Therapy Market Size by Application
Table 35. Global Phage Therapy Sales by Application (2020-2025) & (K Units)
Table 36. Global Phage Therapy Sales Market Share by Application (2020-2025)
Table 37. Global Phage Therapy Market Size by Application (2020-2025) & (M USD)
Table 38. Global Phage Therapy Market Share by Application (2020-2025)
Table 39. Global Phage Therapy Sales Growth Rate by Application (2020-2025)
Table 40. Global Phage Therapy Sales by Region (2020-2025) & (K Units)
Table 41. Global Phage Therapy Sales Market Share by Region (2020-2025)
Table 42. Global Phage Therapy Market Size by Region (2020-2025) & (M USD)
Table 43. Global Phage Therapy Market Size by Region (2020-2025)
Table 44. North America Phage Therapy Sales by Country (2020-2025) & (K Units)
Table 45. North America Phage Therapy Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Phage Therapy Sales by Country (2020-2025) & (K Units)
Table 47. Europe Phage Therapy Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Phage Therapy Sales by Region (2020-2025) & (K Units)
Table 49. Asia Pacific Phage Therapy Market Size by Region (2020-2025) & (M USD)
Table 50. South America Phage Therapy Sales by Country (2020-2025) & (K Units)
Table 51. South America Phage Therapy Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Phage Therapy Sales by Region (2020-2025) & (K Units)
Table 53. Middle East and Africa Phage Therapy Market Size by Region (2020-2025) & (M USD)
Table 54. Global Phage Therapy Production (K Units) by Region(2020-2025)
Table 55. Global Phage Therapy Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Phage Therapy Revenue Market Share by Region (2020-2025)
Table 57. Global Phage Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. North America Phage Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Europe Phage Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Japan Phage Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. China Phage Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 62. NPO Microgen Basic Information
Table 63. NPO Microgen Phage Therapy Product Overview
Table 64. NPO Microgen Phage Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 65. NPO Microgen Business Overview
Table 66. NPO Microgen SWOT Analysis
Table 67. NPO Microgen Recent Developments
Table 68. Qingdao Phagepharm Bio-tech Basic Information
Table 69. Qingdao Phagepharm Bio-tech Phage Therapy Product Overview
Table 70. Qingdao Phagepharm Bio-tech Phage Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 71. Qingdao Phagepharm Bio-tech Business Overview
Table 72. Qingdao Phagepharm Bio-tech SWOT Analysis
Table 73. Qingdao Phagepharm Bio-tech Recent Developments
Table 74. Armata Pharmaceuticals, Inc. Basic Information
Table 75. Armata Pharmaceuticals, Inc. Phage Therapy Product Overview
Table 76. Armata Pharmaceuticals, Inc. Phage Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. Armata Pharmaceuticals, Inc. Business Overview
Table 78. Armata Pharmaceuticals, Inc. SWOT Analysis
Table 79. Armata Pharmaceuticals, Inc. Recent Developments
Table 80. Phaxiam Therapeutics Basic Information
Table 81. Phaxiam Therapeutics Phage Therapy Product Overview
Table 82. Phaxiam Therapeutics Phage Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Phaxiam Therapeutics Business Overview
Table 84. Phaxiam Therapeutics Recent Developments
Table 85. Eliava BioPreparations Basic Information
Table 86. Eliava BioPreparations Phage Therapy Product Overview
Table 87. Eliava BioPreparations Phage Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Eliava BioPreparations Business Overview
Table 89. Eliava BioPreparations Recent Developments
Table 90. Intralytix Basic Information
Table 91. Intralytix Phage Therapy Product Overview
Table 92. Intralytix Phage Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Intralytix Business Overview
Table 94. Intralytix Recent Developments
Table 95. MicroMir Basic Information
Table 96. MicroMir Phage Therapy Product Overview
Table 97. MicroMir Phage Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. MicroMir Business Overview
Table 99. MicroMir Recent Developments
Table 100. Phagelux Basic Information
Table 101. Phagelux Phage Therapy Product Overview
Table 102. Phagelux Phage Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. Phagelux Business Overview
Table 104. Phagelux Recent Developments
Table 105. Pharmex Group, LLC Basic Information
Table 106. Pharmex Group, LLC Phage Therapy Product Overview
Table 107. Pharmex Group, LLC Phage Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. Pharmex Group, LLC Business Overview
Table 109. Pharmex Group, LLC Recent Developments
Table 110. APS Biocontrol Ltd. (APS) Basic Information
Table 111. APS Biocontrol Ltd. (APS) Phage Therapy Product Overview
Table 112. APS Biocontrol Ltd. (APS) Phage Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. APS Biocontrol Ltd. (APS) Business Overview
Table 114. APS Biocontrol Ltd. (APS) Recent Developments
Table 115. ACD Pharma Basic Information
Table 116. ACD Pharma Phage Therapy Product Overview
Table 117. ACD Pharma Phage Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 118. ACD Pharma Business Overview
Table 119. ACD Pharma Recent Developments
Table 120. Proteon Pharmaceuticals Basic Information
Table 121. Proteon Pharmaceuticals Phage Therapy Product Overview
Table 122. Proteon Pharmaceuticals Phage Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 123. Proteon Pharmaceuticals Business Overview
Table 124. Proteon Pharmaceuticals Recent Developments
Table 125. Micreos Basic Information
Table 126. Micreos Phage Therapy Product Overview
Table 127. Micreos Phage Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 128. Micreos Business Overview
Table 129. Micreos Recent Developments
Table 130. Locus Biosciences, Inc Basic Information
Table 131. Locus Biosciences, Inc Phage Therapy Product Overview
Table 132. Locus Biosciences, Inc Phage Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 133. Locus Biosciences, Inc Business Overview
Table 134. Locus Biosciences, Inc Recent Developments
Table 135. NexaBiome Limited Basic Information
Table 136. NexaBiome Limited Phage Therapy Product Overview
Table 137. NexaBiome Limited Phage Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 138. NexaBiome Limited Business Overview
Table 139. NexaBiome Limited Recent Developments
Table 140. PhagePro Basic Information
Table 141. PhagePro Phage Therapy Product Overview
Table 142. PhagePro Phage Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 143. PhagePro Business Overview
Table 144. PhagePro Recent Developments
Table 145. BiomX Basic Information
Table 146. BiomX Phage Therapy Product Overview
Table 147. BiomX Phage Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 148. BiomX Business Overview
Table 149. BiomX Recent Developments
Table 150. INtODEWORLD, Inc. Basic Information
Table 151. INtODEWORLD, Inc. Phage Therapy Product Overview
Table 152. INtODEWORLD, Inc. Phage Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 153. INtODEWORLD, Inc. Business Overview
Table 154. INtODEWORLD, Inc. Recent Developments
Table 155. TechnoPhage Basic Information
Table 156. TechnoPhage Phage Therapy Product Overview
Table 157. TechnoPhage Phage Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 158. TechnoPhage Business Overview
Table 159. TechnoPhage Recent Developments
Table 160. PhageLab Basic Information
Table 161. PhageLab Phage Therapy Product Overview
Table 162. PhageLab Phage Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 163. PhageLab Business Overview
Table 164. PhageLab Recent Developments
Table 165. SciPhage Basic Information
Table 166. SciPhage Phage Therapy Product Overview
Table 167. SciPhage Phage Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 168. SciPhage Business Overview
Table 169. SciPhage Recent Developments
Table 170. Kinzbio Basic Information
Table 171. Kinzbio Phage Therapy Product Overview
Table 172. Kinzbio Phage Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 173. Kinzbio Business Overview
Table 174. Kinzbio Recent Developments
Table 175. Global Phage Therapy Sales Forecast by Region (2026-2035) & (K Units)
Table 176. Global Phage Therapy Market Size Forecast by Region (2026-2035) & (M USD)
Table 177. North America Phage Therapy Sales Forecast by Country (2026-2035) & (K Units)
Table 178. North America Phage Therapy Market Size Forecast by Country (2026-2035) & (M USD)
Table 179. Europe Phage Therapy Sales Forecast by Country (2026-2035) & (K Units)
Table 180. Europe Phage Therapy Market Size Forecast by Country (2026-2035) & (M USD)
Table 181. Asia Pacific Phage Therapy Sales Forecast by Region (2026-2035) & (K Units)
Table 182. Asia Pacific Phage Therapy Market Size Forecast by Region (2026-2035) & (M USD)
Table 183. South America Phage Therapy Sales Forecast by Country (2026-2035) & (K Units)
Table 184. South America Phage Therapy Market Size Forecast by Country (2026-2035) & (M USD)
Table 185. Middle East and Africa Phage Therapy Sales Forecast by Country (2026-2035) & (Units)
Table 186. Middle East and Africa Phage Therapy Market Size Forecast by Country (2026-2035) & (M USD)
Table 187. Global Phage Therapy Sales Forecast by Type (2026-2035) & (K Units)
Table 188. Global Phage Therapy Market Size Forecast by Type (2026-2035) & (M USD)
Table 189. Global Phage Therapy Price Forecast by Type (2026-2035) & (USD/Unit)
Table 190. Global Phage Therapy Sales (K Units) Forecast by Application (2026-2035)
Table 191. Global Phage Therapy Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Phage Therapy Market Size by Type (M USD)
Table 4. Global Phage Therapy Market Size by Application
Table 5. Phage Therapy Market Size Comparison by Region (M USD)
Table 6. Global Phage Therapy Sales (K Units) by Manufacturers (2020-2025)
Table 7. Global Phage Therapy Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Phage Therapy Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Phage Therapy Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Phage Therapy as of 2025)
Table 11. Global Market Phage Therapy Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Phage Therapy Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Phage Therapy Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Phage Therapy Sales by Type (K Units)
Table 27. Global Phage Therapy Market Size by Type (M USD)
Table 28. Global Phage Therapy Sales (K Units) by Type (2020-2025)
Table 29. Global Phage Therapy Sales Market Share by Type (2020-2025)
Table 30. Global Phage Therapy Market Size (M USD) by Type (2020-2025)
Table 31. Global Phage Therapy Market Share by Type (2020-2025)
Table 32. Global Phage Therapy Price (USD/Unit) by Type (2020-2025)
Table 33. Global Phage Therapy Sales (K Units) by Application
Table 34. Global Phage Therapy Market Size by Application
Table 35. Global Phage Therapy Sales by Application (2020-2025) & (K Units)
Table 36. Global Phage Therapy Sales Market Share by Application (2020-2025)
Table 37. Global Phage Therapy Market Size by Application (2020-2025) & (M USD)
Table 38. Global Phage Therapy Market Share by Application (2020-2025)
Table 39. Global Phage Therapy Sales Growth Rate by Application (2020-2025)
Table 40. Global Phage Therapy Sales by Region (2020-2025) & (K Units)
Table 41. Global Phage Therapy Sales Market Share by Region (2020-2025)
Table 42. Global Phage Therapy Market Size by Region (2020-2025) & (M USD)
Table 43. Global Phage Therapy Market Size by Region (2020-2025)
Table 44. North America Phage Therapy Sales by Country (2020-2025) & (K Units)
Table 45. North America Phage Therapy Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Phage Therapy Sales by Country (2020-2025) & (K Units)
Table 47. Europe Phage Therapy Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Phage Therapy Sales by Region (2020-2025) & (K Units)
Table 49. Asia Pacific Phage Therapy Market Size by Region (2020-2025) & (M USD)
Table 50. South America Phage Therapy Sales by Country (2020-2025) & (K Units)
Table 51. South America Phage Therapy Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Phage Therapy Sales by Region (2020-2025) & (K Units)
Table 53. Middle East and Africa Phage Therapy Market Size by Region (2020-2025) & (M USD)
Table 54. Global Phage Therapy Production (K Units) by Region(2020-2025)
Table 55. Global Phage Therapy Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Phage Therapy Revenue Market Share by Region (2020-2025)
Table 57. Global Phage Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. North America Phage Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Europe Phage Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Japan Phage Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. China Phage Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 62. NPO Microgen Basic Information
Table 63. NPO Microgen Phage Therapy Product Overview
Table 64. NPO Microgen Phage Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 65. NPO Microgen Business Overview
Table 66. NPO Microgen SWOT Analysis
Table 67. NPO Microgen Recent Developments
Table 68. Qingdao Phagepharm Bio-tech Basic Information
Table 69. Qingdao Phagepharm Bio-tech Phage Therapy Product Overview
Table 70. Qingdao Phagepharm Bio-tech Phage Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 71. Qingdao Phagepharm Bio-tech Business Overview
Table 72. Qingdao Phagepharm Bio-tech SWOT Analysis
Table 73. Qingdao Phagepharm Bio-tech Recent Developments
Table 74. Armata Pharmaceuticals, Inc. Basic Information
Table 75. Armata Pharmaceuticals, Inc. Phage Therapy Product Overview
Table 76. Armata Pharmaceuticals, Inc. Phage Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. Armata Pharmaceuticals, Inc. Business Overview
Table 78. Armata Pharmaceuticals, Inc. SWOT Analysis
Table 79. Armata Pharmaceuticals, Inc. Recent Developments
Table 80. Phaxiam Therapeutics Basic Information
Table 81. Phaxiam Therapeutics Phage Therapy Product Overview
Table 82. Phaxiam Therapeutics Phage Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Phaxiam Therapeutics Business Overview
Table 84. Phaxiam Therapeutics Recent Developments
Table 85. Eliava BioPreparations Basic Information
Table 86. Eliava BioPreparations Phage Therapy Product Overview
Table 87. Eliava BioPreparations Phage Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Eliava BioPreparations Business Overview
Table 89. Eliava BioPreparations Recent Developments
Table 90. Intralytix Basic Information
Table 91. Intralytix Phage Therapy Product Overview
Table 92. Intralytix Phage Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Intralytix Business Overview
Table 94. Intralytix Recent Developments
Table 95. MicroMir Basic Information
Table 96. MicroMir Phage Therapy Product Overview
Table 97. MicroMir Phage Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. MicroMir Business Overview
Table 99. MicroMir Recent Developments
Table 100. Phagelux Basic Information
Table 101. Phagelux Phage Therapy Product Overview
Table 102. Phagelux Phage Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. Phagelux Business Overview
Table 104. Phagelux Recent Developments
Table 105. Pharmex Group, LLC Basic Information
Table 106. Pharmex Group, LLC Phage Therapy Product Overview
Table 107. Pharmex Group, LLC Phage Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. Pharmex Group, LLC Business Overview
Table 109. Pharmex Group, LLC Recent Developments
Table 110. APS Biocontrol Ltd. (APS) Basic Information
Table 111. APS Biocontrol Ltd. (APS) Phage Therapy Product Overview
Table 112. APS Biocontrol Ltd. (APS) Phage Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. APS Biocontrol Ltd. (APS) Business Overview
Table 114. APS Biocontrol Ltd. (APS) Recent Developments
Table 115. ACD Pharma Basic Information
Table 116. ACD Pharma Phage Therapy Product Overview
Table 117. ACD Pharma Phage Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 118. ACD Pharma Business Overview
Table 119. ACD Pharma Recent Developments
Table 120. Proteon Pharmaceuticals Basic Information
Table 121. Proteon Pharmaceuticals Phage Therapy Product Overview
Table 122. Proteon Pharmaceuticals Phage Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 123. Proteon Pharmaceuticals Business Overview
Table 124. Proteon Pharmaceuticals Recent Developments
Table 125. Micreos Basic Information
Table 126. Micreos Phage Therapy Product Overview
Table 127. Micreos Phage Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 128. Micreos Business Overview
Table 129. Micreos Recent Developments
Table 130. Locus Biosciences, Inc Basic Information
Table 131. Locus Biosciences, Inc Phage Therapy Product Overview
Table 132. Locus Biosciences, Inc Phage Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 133. Locus Biosciences, Inc Business Overview
Table 134. Locus Biosciences, Inc Recent Developments
Table 135. NexaBiome Limited Basic Information
Table 136. NexaBiome Limited Phage Therapy Product Overview
Table 137. NexaBiome Limited Phage Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 138. NexaBiome Limited Business Overview
Table 139. NexaBiome Limited Recent Developments
Table 140. PhagePro Basic Information
Table 141. PhagePro Phage Therapy Product Overview
Table 142. PhagePro Phage Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 143. PhagePro Business Overview
Table 144. PhagePro Recent Developments
Table 145. BiomX Basic Information
Table 146. BiomX Phage Therapy Product Overview
Table 147. BiomX Phage Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 148. BiomX Business Overview
Table 149. BiomX Recent Developments
Table 150. INtODEWORLD, Inc. Basic Information
Table 151. INtODEWORLD, Inc. Phage Therapy Product Overview
Table 152. INtODEWORLD, Inc. Phage Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 153. INtODEWORLD, Inc. Business Overview
Table 154. INtODEWORLD, Inc. Recent Developments
Table 155. TechnoPhage Basic Information
Table 156. TechnoPhage Phage Therapy Product Overview
Table 157. TechnoPhage Phage Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 158. TechnoPhage Business Overview
Table 159. TechnoPhage Recent Developments
Table 160. PhageLab Basic Information
Table 161. PhageLab Phage Therapy Product Overview
Table 162. PhageLab Phage Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 163. PhageLab Business Overview
Table 164. PhageLab Recent Developments
Table 165. SciPhage Basic Information
Table 166. SciPhage Phage Therapy Product Overview
Table 167. SciPhage Phage Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 168. SciPhage Business Overview
Table 169. SciPhage Recent Developments
Table 170. Kinzbio Basic Information
Table 171. Kinzbio Phage Therapy Product Overview
Table 172. Kinzbio Phage Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 173. Kinzbio Business Overview
Table 174. Kinzbio Recent Developments
Table 175. Global Phage Therapy Sales Forecast by Region (2026-2035) & (K Units)
Table 176. Global Phage Therapy Market Size Forecast by Region (2026-2035) & (M USD)
Table 177. North America Phage Therapy Sales Forecast by Country (2026-2035) & (K Units)
Table 178. North America Phage Therapy Market Size Forecast by Country (2026-2035) & (M USD)
Table 179. Europe Phage Therapy Sales Forecast by Country (2026-2035) & (K Units)
Table 180. Europe Phage Therapy Market Size Forecast by Country (2026-2035) & (M USD)
Table 181. Asia Pacific Phage Therapy Sales Forecast by Region (2026-2035) & (K Units)
Table 182. Asia Pacific Phage Therapy Market Size Forecast by Region (2026-2035) & (M USD)
Table 183. South America Phage Therapy Sales Forecast by Country (2026-2035) & (K Units)
Table 184. South America Phage Therapy Market Size Forecast by Country (2026-2035) & (M USD)
Table 185. Middle East and Africa Phage Therapy Sales Forecast by Country (2026-2035) & (Units)
Table 186. Middle East and Africa Phage Therapy Market Size Forecast by Country (2026-2035) & (M USD)
Table 187. Global Phage Therapy Sales Forecast by Type (2026-2035) & (K Units)
Table 188. Global Phage Therapy Market Size Forecast by Type (2026-2035) & (M USD)
Table 189. Global Phage Therapy Price Forecast by Type (2026-2035) & (USD/Unit)
Table 190. Global Phage Therapy Sales (K Units) Forecast by Application (2026-2035)
Table 191. Global Phage Therapy Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Phage Therapy
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Phage Therapy Market Size (M USD), 2025-2035
Figure 5. Global Phage Therapy Market Size (M USD) (2020-2035)
Figure 6. Global Phage Therapy Sales (K Units) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Phage Therapy Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Phage Therapy Product Life Cycle
Figure 13. Phage Therapy Sales Share by Manufacturers in 2025
Figure 14. Global Phage Therapy Revenue Share by Manufacturers in 2025
Figure 15. Phage Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Phage Therapy Average Price (USD/Unit) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Phage Therapy Revenue in 2025
Figure 18. Industry Chain Map of Phage Therapy
Figure 19. Global Phage Therapy Market PEST Analysis
Figure 20. Global Phage Therapy Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Phage Therapy Market Share by Type
Figure 27. Sales Market Share of Phage Therapy by Type (2020-2025)
Figure 28. Sales Market Share of Phage Therapy by Type in 2025
Figure 29. Market Share of Phage Therapy by Type (2020-2025)
Figure 30. Market Share of Phage Therapy by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Phage Therapy Market Share by Application
Figure 33. Global Phage Therapy Sales Market Share by Application (2020-2025)
Figure 34. Global Phage Therapy Sales Market Share by Application in 2025
Figure 35. Global Phage Therapy Market Share by Application (2020-2025)
Figure 36. Global Phage Therapy Market Share by Application in 2025
Figure 37. Global Phage Therapy Sales Growth Rate by Application (2020-2025)
Figure 38. Global Phage Therapy Sales Market Share by Region (2020-2025)
Figure 39. Global Phage Therapy Market Size by Region (2020-2025)
Figure 40. North America Phage Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Phage Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Phage Therapy Sales Market Share by Country in 2024
Figure 43. North America Phage Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Phage Therapy Market Size by Country in 2024
Figure 45. U.S. Phage Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Phage Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Phage Therapy Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Phage Therapy Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Phage Therapy Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Phage Therapy Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Phage Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Phage Therapy Sales Market Share by Country in 2024
Figure 53. Europe Phage Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Phage Therapy Market Size by Country in 2024
Figure 55. Germany Phage Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Phage Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Phage Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Phage Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Phage Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Phage Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Phage Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Phage Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Phage Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Phage Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Phage Therapy Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Phage Therapy Sales Market Share by Region in 2024
Figure 67. Asia Pacific Phage Therapy Market Size by Region in 2024
Figure 68. China Phage Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Phage Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Phage Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Phage Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Phage Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Phage Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Phage Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Phage Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Phage Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Phage Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Phage Therapy Sales and Growth Rate (K Units)
Figure 79. South America Phage Therapy Sales Market Share by Country in 2024
Figure 80. South America Phage Therapy Market Size and Growth Rate (M USD)
Figure 81. South America Phage Therapy Market Size by Country in 2024
Figure 82. Brazil Phage Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Phage Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Phage Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Phage Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Phage Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Phage Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Phage Therapy Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Phage Therapy Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Phage Therapy Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Phage Therapy Market Size by Region in 2024
Figure 92. Saudi Arabia Phage Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Phage Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Phage Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Phage Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Phage Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Phage Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Phage Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Phage Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Phage Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Phage Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Phage Therapy Production Market Share by Region (2020-2025)
Figure 103. North America Phage Therapy Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Phage Therapy Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Phage Therapy Production (K Units) Growth Rate (2020-2025)
Figure 106. China Phage Therapy Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Phage Therapy Sales Forecast by Volume (2020-2035) & (K Units)
Figure 108. Global Phage Therapy Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Phage Therapy Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Phage Therapy Market Share Forecast by Type (2026-2035)
Figure 111. Global Phage Therapy Sales Forecast by Application (2026-2035)
Figure 112. Global Phage Therapy Market Share Forecast by Application (2026-2035)
Figure 1. Product Picture of Phage Therapy
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Phage Therapy Market Size (M USD), 2025-2035
Figure 5. Global Phage Therapy Market Size (M USD) (2020-2035)
Figure 6. Global Phage Therapy Sales (K Units) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Phage Therapy Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Phage Therapy Product Life Cycle
Figure 13. Phage Therapy Sales Share by Manufacturers in 2025
Figure 14. Global Phage Therapy Revenue Share by Manufacturers in 2025
Figure 15. Phage Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Phage Therapy Average Price (USD/Unit) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Phage Therapy Revenue in 2025
Figure 18. Industry Chain Map of Phage Therapy
Figure 19. Global Phage Therapy Market PEST Analysis
Figure 20. Global Phage Therapy Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Phage Therapy Market Share by Type
Figure 27. Sales Market Share of Phage Therapy by Type (2020-2025)
Figure 28. Sales Market Share of Phage Therapy by Type in 2025
Figure 29. Market Share of Phage Therapy by Type (2020-2025)
Figure 30. Market Share of Phage Therapy by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Phage Therapy Market Share by Application
Figure 33. Global Phage Therapy Sales Market Share by Application (2020-2025)
Figure 34. Global Phage Therapy Sales Market Share by Application in 2025
Figure 35. Global Phage Therapy Market Share by Application (2020-2025)
Figure 36. Global Phage Therapy Market Share by Application in 2025
Figure 37. Global Phage Therapy Sales Growth Rate by Application (2020-2025)
Figure 38. Global Phage Therapy Sales Market Share by Region (2020-2025)
Figure 39. Global Phage Therapy Market Size by Region (2020-2025)
Figure 40. North America Phage Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Phage Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Phage Therapy Sales Market Share by Country in 2024
Figure 43. North America Phage Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Phage Therapy Market Size by Country in 2024
Figure 45. U.S. Phage Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Phage Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Phage Therapy Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Phage Therapy Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Phage Therapy Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Phage Therapy Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Phage Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Phage Therapy Sales Market Share by Country in 2024
Figure 53. Europe Phage Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Phage Therapy Market Size by Country in 2024
Figure 55. Germany Phage Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Phage Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Phage Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Phage Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Phage Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Phage Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Phage Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Phage Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Phage Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Phage Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Phage Therapy Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Phage Therapy Sales Market Share by Region in 2024
Figure 67. Asia Pacific Phage Therapy Market Size by Region in 2024
Figure 68. China Phage Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Phage Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Phage Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Phage Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Phage Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Phage Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Phage Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Phage Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Phage Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Phage Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Phage Therapy Sales and Growth Rate (K Units)
Figure 79. South America Phage Therapy Sales Market Share by Country in 2024
Figure 80. South America Phage Therapy Market Size and Growth Rate (M USD)
Figure 81. South America Phage Therapy Market Size by Country in 2024
Figure 82. Brazil Phage Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Phage Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Phage Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Phage Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Phage Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Phage Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Phage Therapy Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Phage Therapy Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Phage Therapy Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Phage Therapy Market Size by Region in 2024
Figure 92. Saudi Arabia Phage Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Phage Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Phage Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Phage Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Phage Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Phage Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Phage Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Phage Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Phage Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Phage Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Phage Therapy Production Market Share by Region (2020-2025)
Figure 103. North America Phage Therapy Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Phage Therapy Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Phage Therapy Production (K Units) Growth Rate (2020-2025)
Figure 106. China Phage Therapy Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Phage Therapy Sales Forecast by Volume (2020-2035) & (K Units)
Figure 108. Global Phage Therapy Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Phage Therapy Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Phage Therapy Market Share Forecast by Type (2026-2035)
Figure 111. Global Phage Therapy Sales Forecast by Application (2026-2035)
Figure 112. Global Phage Therapy Market Share Forecast by Application (2026-2035)
